FDA panel deems antipsychotic safe as add-on for MDD: other recommendations prove mixed.(major depressive disorder)(Report): An article from: Clinical Psychiatry News

This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on May 1, 2009. The length of the article is 1143 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA panel deems antipsychotic safe as add-on for MDD: other recommendations prove mixed.(major depressive disorder)(Report)
Author: Alicia Ault
Publication:Clinical Psychiatry News (Magazine/Journal)
Date: May 1, 2009
Publisher: International Medical News Group
Volume: 37 Issue: 5 Page: 1(2)

Article Type: Report

Distributed by Gale, a part of Cengage Learning